Correlation Between Biovie and Reata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biovie and Reata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovie and Reata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovie Inc and Reata Pharmaceuticals, you can compare the effects of market volatilities on Biovie and Reata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovie with a short position of Reata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovie and Reata Pharmaceuticals.
Diversification Opportunities for Biovie and Reata Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Biovie and Reata is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Biovie Inc and Reata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reata Pharmaceuticals and Biovie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovie Inc are associated (or correlated) with Reata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reata Pharmaceuticals has no effect on the direction of Biovie i.e., Biovie and Reata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biovie and Reata Pharmaceuticals
Given the investment horizon of 90 days Biovie Inc is expected to under-perform the Reata Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Biovie Inc is 1.61 times less risky than Reata Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Reata Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 3,962 in Reata Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 7,005 from holding Reata Pharmaceuticals or generate 176.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 31.99% |
| Values | Daily Returns |
Biovie Inc vs. Reata Pharmaceuticals
Performance |
| Timeline |
| Biovie Inc |
| Reata Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biovie and Reata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovie and Reata Pharmaceuticals
The main advantage of trading using opposite Biovie and Reata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovie position performs unexpectedly, Reata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reata Pharmaceuticals will offset losses from the drop in Reata Pharmaceuticals' long position.| Biovie vs. Inozyme Pharma | Biovie vs. Day One Biopharmaceuticals | Biovie vs. Terns Pharmaceuticals | Biovie vs. Eledon Pharmaceuticals |
| Reata Pharmaceuticals vs. Sarepta Therapeutics | Reata Pharmaceuticals vs. Krystal Biotech | Reata Pharmaceuticals vs. PTC Therapeutics | Reata Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |